MIM
RLYB icon

MetLife Investment Management’s Rallybio RLYB Stock Holding History

MetLife Investment Management’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,122
Closed -$57.2K – 2856
2023
Q3 		$57.2K Hold
2,122
– – ﹤0.01% 2811
2023
Q2 		$96.1K Buy
+2,122
New +$104K ﹤0.01% 2706
2023
Q1 		– Sell
-1,285
Closed -$67.5K – 2813
2022
Q4 		$67.5K Hold
1,285
– – ﹤0.01% 2715
2022
Q3 		$149K Buy
+1,285
New +$114K ﹤0.01% 2466

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

MetLife Investment Management's RLYB Position: Q4 2023 in Review

MetLife Investment Management sold out of Rallybio (RLYB) in Q4 2023, closing a stake of 2,122 shares — an estimated $57.2K sold.

MetLife Investment Management first reported a position in RLYB in Q3 2022 and held it in 4 quarters. The position peaked at $149K in Q3 2022. 54 funds tracked by Wall St. Rank hold RLYB as of Q4 2023.

  • MetLife Investment Management reported no remaining Rallybio position as of Q4 2023 after selling out during the quarter.
  • MetLife Investment Management sold 2,122 Rallybio shares in Q4 2023, an estimated $57.2K.
  • MetLife Investment Management first reported a position in Rallybio in Q3 2022 and held it in 4 quarters.
  • MetLife Investment Management's Rallybio position peaked at $149K in Q3 2022.
  • 54 funds tracked by Wall St. Rank held Rallybio as of Q4 2023.

Based on MetLife Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.